We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Vertex Ventures

News List

Regor Therapeutics Announces Completion of $90 Million Series B Financing prnasia
February 19, 2021
Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing.
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million prnasia
November 09, 2020
Inmagene Biopharmaceuticals, announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors.